Layoffs at TScan Therapeutics
- Layoff events
- 2
- verified and sourced
- Roles reported
- 162
- roles in total
- Announced between
- Nov 2025 to Sep 2026
- Reported by
- U.S. Securities and Exchange Commission, TScan Therapeutics, Massachusetts Executive Office of Labor and Workforce Development, and U.S. SEC
This page records what we could verify and source. It is not a complete record of every job cut at TScan Therapeutics: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| TScan Therapeutics |
Funding
TScan Therapeutics announced a strategic reorganization eliminating approximately 75% of its workforce while focusing resources on in-vivo programs and conserving capital. |
96 | Not known | Waltham, United States | ||
| TScan Therapeutics |
Restructuring
TScan Therapeutics prioritized its heme program and implemented a workforce reduction of 66 employees, approximately 30% of its workforce. |
66 | Not known | Waltham, United States |
2 sources for TScan Therapeutics |
Where this comes from
Every cut listed for TScan Therapeutics was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about TScan Therapeutics? Tell us on our Discord and we will check it.